# The Predictive Role of Preoperative Pentraxin-3 (PTX3) in Metabolic and Inflammatory Outcomes After Roux-en-Y Gastric Bypass

> **NCT07241741** · — · COMPLETED · sponsor: **Istanbul University** · enrollment: 23 (actual)

## Conditions studied

- Obesity
- Metabolic Syndrome
- Insulin Resistance
- Inflammation
- Roux en Y Gastric Bypass
- Chronic Inflammation
- C-Reactive Protein
- Interleukin-6

## Interventions

- **OTHER:** Biomarker Stratification by PTX3

## Key facts

- **NCT ID:** NCT07241741
- **Lead sponsor:** Istanbul University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2015-07-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07241741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07241741, "The Predictive Role of Preoperative Pentraxin-3 (PTX3) in Metabolic and Inflammatory Outcomes After Roux-en-Y Gastric Bypass". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07241741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*